|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 60.59 USD | -3.89% |
|
-0.66% | -20.23% |
| 10-15 | UBS Adjusts Price Target on PTC Therapeutics to $90 From $80, Maintains Buy Rating | MT |
| 10-08 | RBC Cuts Price Target on PTC Therapeutics to $75 From $85, Keeps Sector Perform Rating | MT |
Stock exchange
Nasdaq
PTCT 60.59 $
-3.89%
40.85M
$
Quotes 5-day view: PTC Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-10-19 | 2026-10-20 | 2026-10-21 | 2026-10-22 | 2026-10-23 | |
|---|---|---|---|---|---|
| Last | US$61.53 | US$62.92 | US$62.62 | US$63.04 | US$60.59 |
| Volume | 943,991 | 965,774 | 944,163 | 675,444 | 674,097 |
| Change | +3.87% | +2.26% | -0.48% | +0.67% | -3.89% |
| Opening | US$60.13 | US$62.27 | US$63.14 | US$62.62 | US$62.30 |
| High | US$61.74 | US$63.24 | US$63.74 | US$63.49 | US$63.49 |
| Low | US$59.35 | US$61.58 | US$62.41 | US$62.24 | US$59.97 |
Performance
| 1 day | -3.89% | ||
| 1 week | -0.66% | ||
| Current month | -6.47% | ||
| 1 month | -8.14% | ||
| 3 months | -22.72% | ||
| 6 months | -14.48% | ||
| Current year | -20.23% | ||
| 1 year | -8.91% | ||
| 3 years | +161.05% | ||
| 5 years | +68.35% | ||
| 10 years | +776.85% |
Volumes
marketsDaily volume
674,206
Estimated daily volume
674,206
Avg. Volume 20 sessions
1,022,025
Daily volume ratio
0.66
Avg. Volume 20 sessions USD
61,924,494.75
Record volume 1
28,675,120
Record volume 2
26,581,960
Record volume 3
21,662,070
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
5,226,315,421
Net sales (USD)
1,730,655,000
Number of employees
991
Sales / Employee (USD)
1,746,372
Free-Float
92.69%
Free-Float capitalization (USD)
4,844,200,604
Average Daily Capital Traded
1.18%
Indicators
Moving average 5 days
61.87
Moving average 20 days
62.79
Moving average 50 days
66.8
Moving average 100 days
71.92
Price spread / (MMA5)
+2.11%
Price spread / (MMA20)
+3.64%
Price spread / (MMA50)
+10.25%
Price spread / (MMA100)
+18.70%
RSI 9 days
49.85
RSI 14 days
46.26
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.89% | -0.66% | -8.91% | +161.05% | 5.23B | |
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | |
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | |
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | |
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | |
| Average | -1.03% | +2.63% | +31.59% | +78.37% | 406.07B | |
| Weighted average by Cap. | -0.40% | +3.17% | +40.72% | +80.44% |
Historical Quotes: PTC Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
3752d51862a741c8ff6e12ee2d.eT5Aou6MyWk1GdVUBaXoDqMALUsa0pt-MxxgTzWSUMQ.MFEUwJ_NhB5lTLQsbtGLfZRndQl_gPc9YC40PXTWCLJJRDXAgb27JwxTpg
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 60.59 | 153,021 | 494,227 |
| 15:59:58 | 60.56 | 100 | 341,206 |
| 15:59:58 | 60.56 | 125 | 341,106 |
| 15:59:58 | 60.58 | 100 | 340,981 |
| 15:59:58 | 60.57 | 100 | 340,881 |
| 15:59:58 | 60.57 | 100 | 340,781 |
| 15:59:58 | 60.58 | 390 | 340,681 |
| 15:59:58 | 60.58 | 400 | 340,291 |
| 15:59:58 | 60.58 | 100 | 339,891 |
| 15:59:57 | 60.56 | 100 | 339,791 |
Price Extremes
| 1 week | 59.35 |  | 63.74 |
| 1 month | 58.8 | | 66.26 |
| Current year | 58.8 | | 90.87 |
| 1 year | 58.8 | | 90.87 |
| 3 years | 17.53 | | 90.87 |
| 5 years | 17.53 | | 90.87 |
| 10 years | 4.03 | | 90.87 |
Monthly variations
Annual variations
| 2026 | -20.23% | ||
| 2025 | +68.28% | ||
| 2024 | +63.79% | ||
| 2023 | -27.80% | ||
| 2022 | -4.17% | ||
| 2021 | -34.74% | ||
| 2020 | +27.07% | ||
| 2019 | +39.95% | ||
| 2018 | +105.76% | ||
| 2017 | +52.89% | ||
| 2016 | -66.33% | ||
| 2015 | -37.42% | ||
| 2014 | +205.07% | ||
| 2013 | +2.91% |
- Stock Market
- Stocks
- PTCT Stock
- Quotes PTC Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
